{"id":"W7116952014","doi":"10.1016/j.annonc.2025.10.923","title":"88MO Trastuzumab deruxtecan (T-DXd) + pertuzumab (P) vs taxane + trastuzumab + pertuzumab (THP) for first-line (1L) treatment of Asian patients (pts) with HER2+ advanced/metastatic breast cancer (a/mBC): A DESTINY-Breast09 analysis","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Pertuzumab; Taxane; Trastuzumab; Breast cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001191182,0.0003870578,0.0009184967,0.0002779212,0.0001358721,0.000577142,0.0003739015,0.0004451176,0.003027121],"category_scores_gemma":[0.000812437,0.0001660779,0.00140447,0.0003284079,0.0003385391,0.0006019156,0.0002633787,0.0008984412,0.0002716533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006680934,"about_ca_system_score_gemma":0.0006177185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001107266,"about_ca_topic_score_gemma":0.003795431,"domain_scores_codex":[0.9996032,0.0001799895,0.00002472778,0.00005424474,0.00003444837,0.0001033351],"domain_scores_gemma":[0.9994272,0.0002028525,0.0001225316,0.00003419543,0.00002183111,0.0001914968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8098323,0.007361781,0.05181066,0.0003941287,0.003751713,0.0002431229,0.0002388319,0.002323588,0.01614114,0.0003983116,0.00155953,0.1059448],"study_design_scores_gemma":[0.108968,0.5249136,0.3357332,0.0001316978,0.009554815,0.0008496522,0.0004943982,0.004961064,0.006181632,0.000667634,0.007475247,0.00006902885],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978471,0.0009054581,0.00005808213,0.0001119493,0.00002530021,0.00004883925,0.000214703,0.000006169495,0.0007824907],"genre_scores_gemma":[0.9977503,0.0006602822,0.0001260947,0.0001448835,0.00005463941,0.00003591075,0.0003757305,0.000004592001,0.0008476187],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003027121,"threshold_uncertainty_score":0.01012671,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06237122466736459,"score_gpt":0.4233950909921288,"score_spread":0.3610238663247642,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}